Gene delivery formulations and methods for treatment of...

A - Human Necessities – 61 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

A61K 48/00 (2006.01) A61K 38/18 (2006.01) A61K 38/19 (2006.01) A61K 47/34 (2006.01) A61P 9/10 (2006.01) C07K 14/475 (2006.01) C12N 15/85 (2006.01) C12N 15/87 (2006.01)

Patent

CA 2426582

The present inventors have developed a novel approach for efficient delivery of angiogenic factors to the cardiac and peripheral vasculature that avoids problems with toxicity inherent to existing delivery technologies. Vectors carrying coding sequences for Del-1 or VEGF, or both, can be formulated with poloxamers or other polymers for delivery into ischemic tissue and delivered to the heart by retrograde venous perfusion.

La présente invention concerne une nouvelle approche pour une diffusion efficiente de facteurs angiogéniques dans le système vasculaire cardiaque et périphérique, qui évite les problèmes de toxicité inhérents aux techniques de diffusion existantes. Des vecteurs transportant des séquences de codage pour Del-1 et/ou VEGF peuvent être préparés avec des poloxamères ou autres polymères aux fins de diffusion dans un tissu ischémique, et diffusés dans le coeur par perfusion veineuse rétrograde.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Gene delivery formulations and methods for treatment of... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Gene delivery formulations and methods for treatment of..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Gene delivery formulations and methods for treatment of... will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1906400

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.